{"id":"https://openalex.org/W2134401047","doi":"https://doi.org/10.1186/1471-2091-9-s1-s1","title":"Targeting the UPS as therapy in multiple myeloma","display_name":"Targeting the UPS as therapy in multiple myeloma","alternate_titles":[],"publication_year":2008,"publication_date":"2008-10-21","ids":{"openalex":"https://openalex.org/W2134401047","doi":"https://doi.org/10.1186/1471-2091-9-s1-s1","mag":"2134401047","pmid":"https://pubmed.ncbi.nlm.nih.gov/19007431","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2582802"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2091-9-s1-s1","doi":"https://doi.org/10.1186/1471-2091-9-s1-s1","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2091-9-s1-s1","pdf_url":"https://bmcbiochem.biomedcentral.com/counter/pdf/10.1186/1471-2091-9-S1-S1","source":{"id":"https://openalex.org/S120371716","display_name":"BMC Biochemistry","issn_l":"1471-2091","issn":["1471-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Biochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2134401047"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://bmcbiochem.biomedcentral.com/counter/pdf/10.1186/1471-2091-9-S1-S1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006765393","display_name":"Dharminder Chauhan","orcid":"https://orcid.org/0000-0002-5548-6138","observed_orcids":["https://orcid.org/0000-0002-5548-6138"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Dharminder Chauhan","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. Dharminder_Chauhan@dfci.harvard.edu","Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. Dharminder_Chauhan@dfci.harvard.edu","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084831561","display_name":"Giada Bianchi","orcid":"https://orcid.org/0000-0003-3673-0104","observed_orcids":["https://orcid.org/0000-0003-3673-0104"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giada Bianchi","raw_affiliation_strings":["Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, MA, 02115, USA","Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, MA, 02115, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenneth C Anderson","raw_affiliation_strings":["Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, MA, 02115, USA","Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, MA, 02115, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5006765393"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"],"apc_list":{"value":2170,"currency":"USD","value_usd":2170},"apc_paid":{"value":2170,"currency":"USD","value_usd":2170},"fwci":null,"has_fulltext":true,"cited_by_count":43,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"Suppl 1","first_page":"S1","last_page":"S1"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.7113999724388123,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.7113999724388123,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.2750999927520752,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ubiquitin-proteasome-system","display_name":"ubiquitin-proteasome system","score":0.8379999995231628},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9789999723434448},{"id":"https://openalex.org/keywords/26s-proteasome","display_name":"26S proteasome","score":0.9150000214576721},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8659999966621399},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9819999933242798},{"id":"https://openalex.org/keywords/protein-degradation","display_name":"protein degradation","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.9284712076187134},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.9135771989822388},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7099732160568237},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.625176191329956},{"id":"https://openalex.org/C2992195973","wikidata":"https://www.wikidata.org/wiki/Q33123","display_name":"Protein degradation","level":2,"score":0.5698152184486389},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.5450295805931091},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.5400932431221008},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.5301561951637268},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.5248919725418091},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43728065490722656},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4240385890007019},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3937155306339264},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2793642282485962},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23931795358657837},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18930763006210327},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015853","descriptor_name":"Cysteine Proteinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D025801","descriptor_name":"Ubiquitin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D046988","descriptor_name":"Proteasome Endopeptidase Complex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1186/1471-2091-9-s1-s1","doi":"https://doi.org/10.1186/1471-2091-9-s1-s1","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2091-9-s1-s1","pdf_url":"https://bmcbiochem.biomedcentral.com/counter/pdf/10.1186/1471-2091-9-S1-S1","source":{"id":"https://openalex.org/S120371716","display_name":"BMC Biochemistry","issn_l":"1471-2091","issn":["1471-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Biochemistry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2582802","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2582802/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Biochem","raw_type":"Text"},{"id":"pmid:19007431","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19007431","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC biochemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1186/1471-2091-9-s1-s1","doi":"https://doi.org/10.1186/1471-2091-9-s1-s1","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2091-9-s1-s1","pdf_url":"https://bmcbiochem.biomedcentral.com/counter/pdf/10.1186/1471-2091-9-S1-S1","source":{"id":"https://openalex.org/S120371716","display_name":"BMC Biochemistry","issn_l":"1471-2091","issn":["1471-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Biochemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1431502814","display_name":null,"funder_award_id":"CA 78373","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G286169363","display_name":null,"funder_award_id":"CA100707-01","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4933731489","display_name":"SPORE in Multiple Myeloma","funder_award_id":"P50CA100707","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5276536440","display_name":"Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications","funder_award_id":"R01CA050947","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2134401047.pdf","grobid_xml":"https://content.openalex.org/works/W2134401047.grobid-xml"},"referenced_works_count":112,"referenced_works":["https://openalex.org/W91158829","https://openalex.org/W143368141","https://openalex.org/W172613607","https://openalex.org/W1510153624","https://openalex.org/W1513849811","https://openalex.org/W1517472403","https://openalex.org/W1518640128","https://openalex.org/W1519470329","https://openalex.org/W1520422891","https://openalex.org/W1528751727","https://openalex.org/W1549880413","https://openalex.org/W1551702901","https://openalex.org/W1556426431","https://openalex.org/W1570610869","https://openalex.org/W1589662393","https://openalex.org/W1600462418","https://openalex.org/W1607209090","https://openalex.org/W1646203193","https://openalex.org/W1759028523","https://openalex.org/W1792320115","https://openalex.org/W1863167619","https://openalex.org/W1935443268","https://openalex.org/W1963689482","https://openalex.org/W1963967499","https://openalex.org/W1968229731","https://openalex.org/W1969894269","https://openalex.org/W1980471295","https://openalex.org/W1985632417","https://openalex.org/W1987583882","https://openalex.org/W1988146888","https://openalex.org/W1990185112","https://openalex.org/W1991101546","https://openalex.org/W1991276331","https://openalex.org/W1991915276","https://openalex.org/W1992778132","https://openalex.org/W1995596496","https://openalex.org/W1998790265","https://openalex.org/W1999746307","https://openalex.org/W2003924932","https://openalex.org/W2008744347","https://openalex.org/W2009656063","https://openalex.org/W2010552629","https://openalex.org/W2013294222","https://openalex.org/W2016742872","https://openalex.org/W2020738975","https://openalex.org/W2021242983","https://openalex.org/W2023687151","https://openalex.org/W2026642838","https://openalex.org/W2034941135","https://openalex.org/W2039594026","https://openalex.org/W2040202840","https://openalex.org/W2043049816","https://openalex.org/W2043892945","https://openalex.org/W2043943641","https://openalex.org/W2044920880","https://openalex.org/W2052169053","https://openalex.org/W2052716505","https://openalex.org/W2063533508","https://openalex.org/W2064114299","https://openalex.org/W2067653691","https://openalex.org/W2068696470","https://openalex.org/W2069992059","https://openalex.org/W2073875673","https://openalex.org/W2091403769","https://openalex.org/W2091666251","https://openalex.org/W2091823485","https://openalex.org/W2098671505","https://openalex.org/W2100608938","https://openalex.org/W2101759139","https://openalex.org/W2106735362","https://openalex.org/W2108235071","https://openalex.org/W2109635468","https://openalex.org/W2111650326","https://openalex.org/W2113915760","https://openalex.org/W2120590293","https://openalex.org/W2122730639","https://openalex.org/W2124560610","https://openalex.org/W2126267349","https://openalex.org/W2126885291","https://openalex.org/W2127760782","https://openalex.org/W2131612416","https://openalex.org/W2132485651","https://openalex.org/W2132535068","https://openalex.org/W2133986577","https://openalex.org/W2134791874","https://openalex.org/W2138077682","https://openalex.org/W2138102966","https://openalex.org/W2140639593","https://openalex.org/W2143938165","https://openalex.org/W2145216906","https://openalex.org/W2145412346","https://openalex.org/W2146502962","https://openalex.org/W2148537814","https://openalex.org/W2150841236","https://openalex.org/W2151191257","https://openalex.org/W2152065071","https://openalex.org/W2152091753","https://openalex.org/W2152290005","https://openalex.org/W2155330223","https://openalex.org/W2159860846","https://openalex.org/W2166043738","https://openalex.org/W2166427186","https://openalex.org/W2166747788","https://openalex.org/W2168268910","https://openalex.org/W2169295136","https://openalex.org/W2170192548","https://openalex.org/W2171513236","https://openalex.org/W2496024239","https://openalex.org/W2529963971","https://openalex.org/W2982280349","https://openalex.org/W4231501332","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W7098885875","https://openalex.org/W2141253852","https://openalex.org/W2143938165","https://openalex.org/W2068100481","https://openalex.org/W2065375340","https://openalex.org/W2408884886","https://openalex.org/W66356296","https://openalex.org/W3032840474","https://openalex.org/W2069791927","https://openalex.org/W2126947411"],"abstract_inverted_index":{"The":[0,15,31,72],"coordinated":[1],"regulation":[2],"of":[3,44,51,63,75,85,94,107,119],"cellular":[4,13,29],"protein":[5,22],"synthesis":[6],"and":[7,54,116,135,149],"degradation":[8,23,46],"is":[9,25,34,78],"essential":[10],"for":[11,27,68,91],"normal":[12,28],"functioning.":[14],"ubiquitin":[16],"proteasome":[17,33,64,88,142],"system":[18],"mediates":[19],"the":[20,61,81,86,92,105,117],"intracellular":[21,49],"that":[24,38,127],"required":[26],"homeostasis.":[30],"26S":[32],"a":[35,101],"multi-enzyme":[36],"protease":[37],"degrades":[39],"redundant":[40],"proteins;":[41],"conversely,":[42],"inhibition":[43],"proteasomal":[45],"results":[47],"in":[48,70,104,159,165],"aggregation":[50],"unwanted":[52],"proteins":[53],"cell":[55],"death.":[56],"This":[57],"observation":[58],"led":[59],"to":[60,161],"development":[62,118],"inhibitors":[65],"as":[66],"therapeutics":[67],"use":[69],"cancer.":[71],"clinical":[73,157],"applicability":[74],"targeting":[76],"proteasomes":[77],"exemplified":[79],"by":[80],"recent":[82],"FDA":[83],"approval":[84],"first":[87],"inhibitor,":[89],"bortezomib,":[90,148],"treatment":[93,106],"relapsed/refractory":[95],"multiple":[96,166],"myeloma.":[97,167],"Although":[98],"bortezomib":[99],"represents":[100],"major":[102],"advance":[103],"this":[108],"disease,":[109],"it":[110],"can":[111,130],"be":[112],"associated":[113],"with":[114],"toxicity":[115],"drug":[120,133],"resistance.":[121],"Importantly,":[122],"extensive":[123],"preclinical":[124],"studies":[125],"suggest":[126],"combination":[128],"therapies":[129],"both":[131],"circumvent":[132],"resistance":[134],"reduce":[136],"toxicity.":[137],"In":[138],"addition,":[139],"promising":[140],"novel":[141],"inhibitors,":[143],"which":[144],"are":[145,155],"distinct":[146],"from":[147,172],"exhibit":[150],"equipotent":[151],"anti-multiple":[152],"myeloma":[153],"activities,":[154],"undergoing":[156],"evaluation":[158],"order":[160],"improve":[162],"patient":[163],"outcome":[164],"PUBLICATION":[168],"HISTORY":[169],":":[170],"Republished":[171],"Current":[173],"BioData's":[174],"Targeted":[175],"Proteins":[176],"database":[177],"(TPdb;":[178],"http://www.targetedproteinsdb.com).":[179]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2134401047","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
